Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
P Garcia-Pavia, C Rapezzi, Y Adler, M Arad… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D …
P Garcia‐Pavia, C Rapezzi, Y Adler… - European journal of …, 2021 - Wiley Online Library
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
Transthyretin cardiac amyloidosis
Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart
failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the …
failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the …
Prevalence, characteristics and outcomes of older patients with hereditary versus wild‐type transthyretin amyloid cardiomyopathy
A Porcari, Y Razvi, A Masi, R Patel… - European journal of …, 2023 - Wiley Online Library
Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is often assumed to be associated
with wild‐type TTR genotype (ATTRwt) in elderly patients (aged≥ 70), some of whom are …
with wild‐type TTR genotype (ATTRwt) in elderly patients (aged≥ 70), some of whom are …
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey
Aim To investigate the prevalence of amyloid cardiomyopathy (AC) and the diagnostic
accuracy of echocardiographic red flags of AC among consecutive adult patients …
accuracy of echocardiographic red flags of AC among consecutive adult patients …
A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
DR Davies, MM Redfield, CG Scott… - JAMA …, 2022 - jamanetwork.com
Importance Transthyretin amyloid cardiomyopathy (ATTR-CM) is a form of heart failure (HF)
with preserved ejection fraction (HFpEF). Technetium Tc 99m pyrophosphate scintigraphy …
with preserved ejection fraction (HFpEF). Technetium Tc 99m pyrophosphate scintigraphy …
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review
C Rapezzi, A Aimo, M Serenelli, A Barison… - Journal of the American …, 2022 - jacc.org
Over the last year, 5 national or international scientific societies have issued documents
regarding cardiac amyloidosis (CA) to highlight the emerging clinical science, raise …
regarding cardiac amyloidosis (CA) to highlight the emerging clinical science, raise …
Cardiac amyloidosis and aortic stenosis: a state-of-the-art review
Cardiac amyloidosis is caused by the extracellular deposition of amyloid fibrils in the heart,
involving not only the myocardium but also any cardiovascular structure. Indeed, this …
involving not only the myocardium but also any cardiovascular structure. Indeed, this …